A Two-Arm Chemoprevention Trial in Familial Adenomatous Polyposis Coli Patients Using the Purified Free Fatty Acid, Eicosapentaenoic Acid.
- Registry ID
- EUCTR2006-002836-18
- Source registry
- EUCTR
- Status
- Completed
- Phase
- PHASE2
- Sponsor
- S.L.A. Pharma (UK) Ltd
- Start date
- 2006-07-03
- Completion date
- 2008-04-25
- Last update
- 2026-08-16
Conditions
- Familial adenomatous polyposis (FAP)
Summary
To determine whether the polyp burden of patients with genetically determined colorectal polyp syndrome (namely Familial Polyposis Coli) be reduced by regular treatment with high concentration eicosapentaenoic acid (EPA) as the free fatty acid.
Locations
View on source registry